<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37893078</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>05</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Metabolic Fingerprinting for the Diagnosis of Clinically Similar Long COVID and Fibromyalgia Using a Portable FT-MIR Spectroscopic Combined with Chemometrics.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2704</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines11102704</ELocationID><Abstract><AbstractText>Post Acute Sequelae of SARS-CoV-2 infection (PASC or Long COVID) is characterized by lingering symptomatology post-initial COVID-19 illness that is often debilitating. It is seen in up to 30-40% of individuals post-infection. Patients with Long COVID (LC) suffer from dysautonomia, malaise, fatigue, and pain, amongst a multitude of other symptoms. Fibromyalgia (FM) is a chronic musculoskeletal pain disorder that often leads to functional disability and severe impairment of quality of life. LC and FM share several clinical features, including pain that often makes them indistinguishable. The aim of this study is to develop a metabolic fingerprinting approach using portable Fourier-transform mid-infrared (FT-MIR) spectroscopic techniques to diagnose clinically similar LC and FM. Blood samples were obtained from LC (<i>n</i> = 50) and FM (<i>n</i> = 50) patients and stored on conventional bloodspot protein saver cards. A semi-permeable membrane filtration approach was used to extract the blood samples, and spectral data were collected using a portable FT-MIR spectrometer. Through the deconvolution analysis of the spectral data, a distinct spectral marker at 1565 cm<sup>-1</sup> was identified based on a statistically significant analysis, only present in FM patients. This IR band has been linked to the presence of side chains of glutamate. An OPLS-DA algorithm created using the spectral region 1500 to 1700 cm<sup>-1</sup> enabled the classification of the spectra into their corresponding classes (Rcv &gt; 0.96) with 100% accuracy and specificity. This high-throughput approach allows unique metabolic signatures associated with LC and FM to be identified, allowing these conditions to be distinguished and implemented for in-clinic diagnostics, which is crucial to guide future therapeutic approaches.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hackshaw</LastName><ForeName>Kevin V</ForeName><Initials>KV</Initials><Identifier Source="ORCID">0000-0002-9780-7171</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Division of Rheumatology, Dell Medical School, The University of Texas, 1601 Trinity St., Austin, TX 78712, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Siyu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Food Science and Technology, The Ohio State University, Columbus, OH 43210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Haona</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Food Science and Technology, The Ohio State University, Columbus, OH 43210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lamo Castellvi</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Food Science and Technology, The Ohio State University, Columbus, OH 43210, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Campus Sescelades, Departament d'Enginyeria Qu&#xed;mica, Universitat Rovira i Virgili, Av. Pa&#xef;sos Catalans 26, 43007 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aziz</LastName><ForeName>Rija</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Dell Medical School, The University of Texas, 1601 Trinity St., Austin, TX 78712, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nuguri</LastName><ForeName>Shreya Madhav</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Food Science and Technology, The Ohio State University, Columbus, OH 43210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Lianbo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center of Biostatistics and Bioinformatics, The Ohio State University, Columbus, OH 43210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osuna-Diaz</LastName><ForeName>Michelle M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Dell Medical School, The University of Texas, 1601 Trinity St., Austin, TX 78712, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brode</LastName><ForeName>W Michael</ForeName><Initials>WM</Initials><Identifier Source="ORCID">0009-0007-0930-478X</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Dell Medical School, The University of Texas, 1601 Trinity St., Austin, TX 78712, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sebastian</LastName><ForeName>Katherine R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Dell Medical School, The University of Texas, 1601 Trinity St., Austin, TX 78712, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giusti</LastName><ForeName>M Monica</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-2348-3530</Identifier><AffiliationInfo><Affiliation>Department of Food Science and Technology, The Ohio State University, Columbus, OH 43210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Saona</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Food Science and Technology, The Ohio State University, Columbus, OH 43210, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R61 NS117211</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R61NS117211</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">blood</Keyword><Keyword MajorTopicYN="N">chemometrics</Keyword><Keyword MajorTopicYN="N">fibromyalgia</Keyword><Keyword MajorTopicYN="N">in-clinic disease diagnostics</Keyword><Keyword MajorTopicYN="N">metabolic fingerprinting</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV-2 (PASC)/long COVID</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>11</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>11</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37893078</ArticleId><ArticleId IdType="pmc">PMC10604557</ArticleId><ArticleId IdType="doi">10.3390/biomedicines11102704</ArticleId><ArticleId IdType="pii">biomedicines11102704</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence. Scottish Intercollegiate Guidelines Network. Royal College of General Practitioners  COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19.  [(accessed on 12 May 2023)].  Available online:  https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742.</Citation></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: A meta-analysis and systematic review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Florencio L.L., Cuadrado M.L., Plaza-Manzano G., Navarro-Santana M. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Intern. Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi M.S., Omrani O.A., Fawzy N.A., Shaar B.A., Almamlouk R., Riaz M., Obeidat M., Obeidat Y., Gerberi D., Taha R.M., et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: A systematic review and meta-analysis. Clin. Microbiol. Infect. 2022;28:657&#x2013;666. doi: 10.1016/j.cmi.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-term sequelae of COVID-19: A systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  COVID-19 Weekly Epidemiological Update on COVID-19. 4 January 2023. Edition 124.  [(accessed on 15 May 2023)].  Available online:  https://www.who.int/publications/m/item/weekly-epidemiological-update-on-COVID-19-4.january-2023.</Citation></Reference><Reference><Citation>Komaroff A.L., Lipkin W.I. ME/CFS and Long COVID share similar symptoms and biological abnormalities: Road map to the literature. Front. Med. 2023;10:1187163. doi: 10.3389/fmed.2023.1187163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider S., Janowski A.J., Lesnak J.B., Hayashi K., Dailey D.L., Chimenti R., Frey-Law L.A., Sluka K.A., Berardi G. A comparison of pain, fatigue, and function between post&#x2013;COVID-19 condition, fibromyalgia, and chronic fatigue syndrome: A survey study. Pain. 2023;164:385&#x2013;401. doi: 10.1097/j.pain.0000000000002711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002711</ArticleId><ArticleId IdType="pmc">PMC9797623</ArticleId><ArticleId IdType="pubmed">36006296</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert N., Corps S., El-Azab S.A., Ramrakhiani N.S., Barisano A., Yu L., Pinto M.D. COVID-19 surviors&#x2019; report of the timing duration, and health impacts of Post-Acute Sequelae of ASRS-CoV-2 (PASC) infection. MedRxiv. 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.22.21254026</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long COVIDmechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>El Tallawy S.N., Perglozzi J.V., Ahmed R.S., Kaki A.M., Naglub M.S., Lequang J.K., Hadarah M.M. Pain Management in the Post-COVID Era- An Update: A Narrative Review. Pain Ther. 2021;12:423&#x2013;448. doi: 10.1007/s40122-023-00486-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40122-023-00486-1</ArticleId><ArticleId IdType="pmc">PMC9971680</ArticleId><ArticleId IdType="pubmed">36853484</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvez-S&#xe1;nchez C.M., Reyes del Paso G.A. Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives. J. Clin. Med. 2020;9:1219. doi: 10.3390/jcm9041219.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9041219</ArticleId><ArticleId IdType="pmc">PMC7230253</ArticleId><ArticleId IdType="pubmed">32340369</ArticleId></ArticleIdList></Reference><Reference><Citation>Ablin J.N., Wolfe F. A Comparative Evaluation of the 2011 and 2016 Criteria for Fibromyalgia. J. Rheumatol. 2017;44:1271&#x2013;1276. doi: 10.3899/jrheum.170095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.170095</ArticleId><ArticleId IdType="pubmed">28572464</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;user W., Ablin J., Fitzcharles M.-A., Littlejohn G., Luciano J.V., Usui C., Walitt B. Fibromyalgia. Nat. Rev. Dis. Prim. 2015;1:15022. doi: 10.1038/nrdp.2015.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2015.22</ArticleId><ArticleId IdType="pubmed">27189527</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith H.S., Harris R., Clauw D. Fibromyalgia: An afferent processing disorder leading to a complex pain generalized syndrome. Pain Physician. 2011;14:217&#x2013;246. doi: 10.36076/ppj.2011/14/E217.</Citation><ArticleIdList><ArticleId IdType="doi">10.36076/ppj.2011/14/E217</ArticleId><ArticleId IdType="pubmed">21412381</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe F., Fitzcharles M.A., Goldenberg D.L., Hauser W., Katz R.L., Mease P.J., Russell A.S., Jon Russell I., Walitt B. Comparison of physician-based and patient-based criteria for the diagnosis of fibromyalgia. Arthritis Care Res. 2016;68:652&#x2013;659. doi: 10.1002/acr.22742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22742</ArticleId><ArticleId IdType="pubmed">26414294</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe F., Schmukler J., Jamal S., Castrejon I., Gibson K.A., Srinivasan S., Hauser W., Pincus T. Diagnosis of fibromyalgia: Disagreement between fibromyalgia criteria and clinician-based fibromyalgia diagnosis in a university clinic. Arthritis Care Res. 2019;71:343&#x2013;351. doi: 10.1002/acr.23731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.23731</ArticleId><ArticleId IdType="pubmed">30724039</ArticleId></ArticleIdList></Reference><Reference><Citation>Walitt B., Katz R.S., Bergman M.J., Wolfe F. Three-quarters of persons in the US population reporting a clinical diagnosis of fibromyalgia do not satisfy fibromyalgia criteria: The 2012 national health interview survey. PLoS ONE. 2016;11:e0157235. doi: 10.1371/journal.pone.0157235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0157235</ArticleId><ArticleId IdType="pmc">PMC4900652</ArticleId><ArticleId IdType="pubmed">27281286</ArticleId></ArticleIdList></Reference><Reference><Citation>Copley M., Kozminski B., Gentile N., Geyer R., Friedly J. Post-Acute Sequelae of SARS-CoV-2 (PASC): Musculoskeletal Conditions and Pain. Phys. Med. Rehabil. Clin. 2023 doi: 10.1016/j.pmr.2023.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmr.2023.04.008</ArticleId><ArticleId IdType="pmc">PMC10211999</ArticleId><ArticleId IdType="pubmed">37419534</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohabbat A.B., Mohabbat N.M.L., Wight E.C. Fibromyalgia and chronic fatigue syndrome in the age of COVID-19. Mayo Clin. Proc. Innov. Qual. Outcomes. 2020;4:764&#x2013;766. doi: 10.1016/j.mayocpiqo.2020.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocpiqo.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7661943</ArticleId><ArticleId IdType="pubmed">33204998</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F., G&#xfc;neri F.D., Karde&#x15f; S. Long COVID: Rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin. Rheumatol. 2022;41:289&#x2013;296. doi: 10.1007/s10067-021-05942-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05942-x</ArticleId><ArticleId IdType="pmc">PMC8553494</ArticleId><ArticleId IdType="pubmed">34713356</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Nijs J., Giordano R., Arendt-Nielsen L. Precision management of post-COVID pain: An evidence and clinical-based approach. Eur. J. Pain. 2023;27:9. doi: 10.1002/ejp.2095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.2095</ArticleId><ArticleId IdType="pubmed">36852606</ArticleId></ArticleIdList></Reference><Reference><Citation>Magdy R., Eid R.A., Fathy W., Abdel-Aziz M.M., Ibrahim R.E., Yehia A., Hussein M. Characteristics and risk factors of persistent neuropathic pain in recovered COVID-19 patients. Pain Med. 2022;23:774&#x2013;781. doi: 10.1093/pm/pnab341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pm/pnab341</ArticleId><ArticleId IdType="pmc">PMC8755258</ArticleId><ArticleId IdType="pubmed">34931670</ArticleId></ArticleIdList></Reference><Reference><Citation>Bileviciute-Ljungar I., Norrefalk J.R., Borg K. Pain burden in post-COVID-19 syndrome following mild COVID-19 infection. J. Clin. Med. 2022;11:771. doi: 10.3390/jcm11030771.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030771</ArticleId><ArticleId IdType="pmc">PMC8836662</ArticleId><ArticleId IdType="pubmed">35160223</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson E., Lam C., Axeen S., Vosooghi A., Schneberk T. 28EMF The Opioid Epidemic Meets the Coronavirus Pandemic: Rates and Patient Characteristics of Emergency Department Visits for Opiate Use Disorder During the COVID-19 Pandemic in the Los Angeles County Public Hospital System. Ann. Emerg. Med. 2021;78:S14. doi: 10.1016/j.annemergmed.2021.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2021.07.029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasserman R.A., Brummett C.M., Goesling J., Tsodikov A., Hassett A.L. Characteristics of chronic pain patients who take opioids and persistently report high pain intensity. Reg. Anesth. Pain Med. 2014;39:13&#x2013;17. doi: 10.1097/AAP.0000000000000024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AAP.0000000000000024</ArticleId><ArticleId IdType="pmc">PMC3960717</ArticleId><ArticleId IdType="pubmed">24310048</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzcharles M.A., Gamsa P.A., Ware M.A., Shir Y. Opioid use, misuse, and abuse in patients labeled as fibromyalgia. Am. J. Med. 2011;124:955&#x2013;960. doi: 10.1016/j.amjmed.2011.05.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2011.05.031</ArticleId><ArticleId IdType="pubmed">21962316</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips K., Clauw D.J. Central pain mechanisms in the rheumatic diseases: Future directions. Arthritis Rheum. 2013;65:291&#x2013;302. doi: 10.1002/art.37739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.37739</ArticleId><ArticleId IdType="pmc">PMC3610409</ArticleId><ArticleId IdType="pubmed">23045168</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine (IOM) Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research. National Academies Press; Washington, DC, USA: 2011.</Citation><ArticleIdList><ArticleId IdType="pubmed">22553896</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezei L., Murinson B.B. Pain education in North American medical schools. J. Pain. 2011;12:1199&#x2013;1208. doi: 10.1016/j.jpain.2011.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2011.06.006</ArticleId><ArticleId IdType="pubmed">21945594</ArticleId></ArticleIdList></Reference><Reference><Citation>Morley-Forster P.K., Pergolizzi J.V., Taylor R., Jr., Axford-Gatley R.A., Sellers E.M. Mitigating the risk of opioid abuse through a balanced undergraduate pain medicine curriculum. J. Pain Res. 2013;6:791&#x2013;801. doi: 10.2147/JPR.S47192.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S47192</ArticleId><ArticleId IdType="pmc">PMC3862507</ArticleId><ArticleId IdType="pubmed">24353438</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackshaw K.V., Miller J.S., Aykas D.P., Rodriguez-Saona L. vibrational spectroscopy for identification of metabolites in biologic samples. Molecules. 2020;25:4725. doi: 10.3390/molecules25204725.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25204725</ArticleId><ArticleId IdType="pmc">PMC7587585</ArticleId><ArticleId IdType="pubmed">33076318</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackshaw K.V. The search for biomarkers in fibromyalgia. Diagnostics. 2021;11:156. doi: 10.3390/diagnostics11020156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11020156</ArticleId><ArticleId IdType="pmc">PMC7911687</ArticleId><ArticleId IdType="pubmed">33494476</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu S., Cai Y., Yao H., Lin C., Xie Y., Tang S., Zhang A. Small molecule metabolites: Discovery of bi-omarkers and therapeutic targets. Signal Transduct. Target. Ther. 2023;8:132. doi: 10.1038/s41392-023-01399-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01399-3</ArticleId><ArticleId IdType="pmc">PMC10026263</ArticleId><ArticleId IdType="pubmed">36941259</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao S., Bao H., Nuguri S.M., Yu L., Mikulik Z., Osuna-Diaz M.M., Sebastian K.R., Hackshaw K.V., Rodriguez-Saona L. Rapid biomarker-based diagnosis of fibromyalgia syndrome and related rheumatologic disorders by portable FT-IR spectroscopic techniques. Biomedicines. 2023;11:712. doi: 10.3390/biomedicines11030712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11030712</ArticleId><ArticleId IdType="pmc">PMC10044908</ArticleId><ArticleId IdType="pubmed">36979691</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullano S.A., Bianco M.G., Greco M., Mazzuca D., Nistic&#xf2; S.P., Fiorillo A.S. FT-IR saliva analysis for the diagnosis of psoriasis: A pilot study. Biomed. Signal Process. Control. 2022;74:103525. doi: 10.1016/j.bspc.2022.103525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bspc.2022.103525</ArticleId></ArticleIdList></Reference><Reference><Citation>Falamas A., Faur C.I., Ciupe S., Chirila M., Rotaru H., Hedesiu M., Cinta Pinzaru S. Rapid and noninva-sive diagnosis of oral and oropharyngeal cancer based on micro-Raman and FT-IR spectra of saliva. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2021;252:119477. doi: 10.1016/j.saa.2021.119477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.saa.2021.119477</ArticleId><ArticleId IdType="pubmed">33545509</ArticleId></ArticleIdList></Reference><Reference><Citation>Lilo T., Morais C.L.M., Shenton C., Ray A., Gurusinghe N. Revising Fourier-transform infrared (FT-IR) and Raman spectroscopy towards brain cancer detection. Photodiagnosis Photodyn. Ther. 2022;38:102785. doi: 10.1016/j.pdpdt.2022.102785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdpdt.2022.102785</ArticleId><ArticleId IdType="pubmed">35231616</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Saona L., Aykas D.P., Borba K.R., Urtubia A. Miniaturization of optical sensors and their poten-tial for high-throughput screening of foods. Curr. Opin. Food Sci. 2020;31:136&#x2013;150. doi: 10.1016/j.cofs.2020.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cofs.2020.04.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackshaw K.V., Aykas D.P., Sigurdson G.T., Plans M., Madiai F., Yu L., Buffington C.A.T., Giusti M.M., Rodriguez-Saona L. Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disor-ders. J. Biol. Chem. 2019;294:2555&#x2013;2568. doi: 10.1074/jbc.RA118.005816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.005816</ArticleId><ArticleId IdType="pmc">PMC6378985</ArticleId><ArticleId IdType="pubmed">30523152</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackshaw K.V., Rodriguez-Saona L., Plans M., Bell L.N., Buffington C.A.T. A bloodspot-based diagnostic test for fibromyalgia syndrome and related disorders. Analyst. 2013;138:4453. doi: 10.1039/c3an36615d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c3an36615d</ArticleId><ArticleId IdType="pubmed">23595128</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Xiao M., Wang Y., Peng S., Chen Y., Zhang D., Zhang D., Guo Y., Wang X., Luo H., et al. Fast Screening and Primary Diagnosis of COVID-19 by ATR&#x2013;FT-IR. Anal. Chem. 2021;93:2191&#x2013;2199. doi: 10.1021/acs.analchem.0c04049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.0c04049</ArticleId><ArticleId IdType="pubmed">33427452</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood B.R., Kochan K., Bedolla D.E., Salazar-Quiroz N., Grimley S.L., Perez-Guaita D., Baker M.J., Vongsvivut J., Tobin M.J., Bambery K.R., et al. Infrared Based Saliva Screening Test for COVID-19. Angew. Chem. Int. Ed. 2021;60:17102&#x2013;17107. doi: 10.1002/anie.202104453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.202104453</ArticleId><ArticleId IdType="pmc">PMC8222893</ArticleId><ArticleId IdType="pubmed">34043272</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento M.H.C., Marcarini W.D., Folli G.S., da Silva Filho W.G., Barbosa L.L., de Paulo E.H., Vassallo P.F., Mill J.G., Barauna V.G., Martin F.L., et al. Noninvasive Diagnostic for COVID-19 from Saliva Biofluid via FTIR Spectroscopy and Multivariate Analysis. Anal. Chem. 2022;94:2425&#x2013;2433. doi: 10.1021/acs.analchem.1c04162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.1c04162</ArticleId><ArticleId IdType="pubmed">35076208</ArticleId></ArticleIdList></Reference><Reference><Citation>Barauna V.G., Singh M.N., Barbosa L.L., Marcarini W.D., Vassallo P.F., Mill J.G., Ribeiro-Rodrigues R., Campos L.C.G., Warnke P.H., Martin F.L. Ultrarapid On-Site Detection of SARS-CoV-2 Infection Using Simple ATR-FTIR Spectroscopy and an Analysis Algorithm: High Sensitivity and Specificity. Anal. Chem. 2021;93:2950&#x2013;2958. doi: 10.1021/acs.analchem.0c04608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.0c04608</ArticleId><ArticleId IdType="pubmed">33481583</ArticleId></ArticleIdList></Reference><Reference><Citation>Dierckx T., van Elslande J., Salmela H., Decru B., Wauters E., Gunst J., Van Herck Y., Wauters J., Stessel B., Vermeersch P. The metabolic fingerprint of COVID-19 severity. MedRxiv. 2020;12:2020-11. doi: 10.1101/2020.11.09.20228221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.09.20228221</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett R.M., Friend R., Jones K.D., Ward R., Han B.K., Ross R.L. The Revised Fibromyalgia Impact Questionnaire (FIQR): Validation and psychometric properties. Arthritis Res. Ther. 2009;11:R120. doi: 10.1186/ar2783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2783</ArticleId><ArticleId IdType="pmc">PMC2745803</ArticleId><ArticleId IdType="pubmed">19664287</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck A.T. An Inventory for Measuring Depression. Arch. Gen. Psychiatry. 1961;4:561. doi: 10.1001/archpsyc.1961.01710120031004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.1961.01710120031004</ArticleId><ArticleId IdType="pubmed">13688369</ArticleId></ArticleIdList></Reference><Reference><Citation>Friend R., Bennett R.M. Distinguishing fibromyalgia from rheumatoid arthritis and systemic lupus in clinical questionnaires: An analysis of the revised Fibromyalgia Impact Questionnaire (FIQR) and its variant, the Symptom Impact Questionnaire (SIQR), along with pain locations. Arthritis Res. Ther. 2011;13:R58. doi: 10.1186/ar3311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3311</ArticleId><ArticleId IdType="pmc">PMC3132053</ArticleId><ArticleId IdType="pubmed">21477308</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrot S., Bouhassira D., Fermanian J. CEDR (Cercle d&#x2019;Etude de la Douleur en Rhumatologie) Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST) Pain. 2010;150:250&#x2013;256. doi: 10.1016/j.pain.2010.03.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2010.03.034</ArticleId><ArticleId IdType="pubmed">20488620</ArticleId></ArticleIdList></Reference><Reference><Citation>Greening D.W., Simpson R.J. A centrifugal ultrafiltration strategy for isolating the low-molecular weight (&#x2264;25K) component of human plasma proteome. J. Proteom. 2010;73:637&#x2013;648. doi: 10.1016/j.jprot.2009.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprot.2009.09.013</ArticleId><ArticleId IdType="pubmed">19782775</ArticleId></ArticleIdList></Reference><Reference><Citation>Wold S., Antti H., Lindgren F., &#xd6;hman J. Orthogonal signal correction of near-infrared spectra. Chemom. Intell. Lab. Syst. 1998;44:175&#x2013;185. doi: 10.1016/S0169-7439(98)00109-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-7439(98)00109-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoot M., Kapper C., van Kollenburg G.H., Postma G.J., van Kessel G., Buydens L.M.C., Jansen J.J. In-vestigating the need for preprocessing of near-infrared spectroscopic data as a function of sample size. Chemom. Intell. Lab. Syst. 2020;204:104105. doi: 10.1016/j.chemolab.2020.104105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chemolab.2020.104105</ArticleId></ArticleIdList></Reference><Reference><Citation>Shariff M.I.F., Ladep N.G., Cox I.J., Williams H.R.T., Okeke E., Malu A., Thillainayagam A.V., Crossey M.M.E., Khan S.A., Thomas H.C., et al. Characterization of Urinary Biomarkers of Hepatocellular Carcino-ma Using Magnetic Resonance Spectroscopy in a Nigerian Population. J. Proteome Res. 2010;9:1096&#x2013;1103. doi: 10.1021/pr901058t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr901058t</ArticleId><ArticleId IdType="pubmed">19968328</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerhuis J.A., Hoefsloot H.C.J., Smit S., Vis D.J., Smilde A.K., van Velzen E.J.J., van Duijnhoven J.P.M., van Dorsten F.A. Assessment of PLSDA cross validation. Metabolomics. 2008;4:81&#x2013;89. doi: 10.1007/s11306-007-0099-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-007-0099-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins J., Brenner L., Tumosa C.S. Variation of the Amide I and Amide II peak absorbance ratio in human hair as measured by Fourier transform infrared spectroscopy. Forensic Sci. Int. 1991;50:61&#x2013;65. doi: 10.1016/0379-0738(91)90134-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0379-0738(91)90134-5</ArticleId><ArticleId IdType="pubmed">1937307</ArticleId></ArticleIdList></Reference><Reference><Citation>Takada T., Nijman S., Denaxas S., Snell K.I.E., Uijl A., Nguyen T.-L., Asselbergs F.W., Debray T.P.A. In-ternal-external cross-validation helped to evaluate the generalizability of prediction models in large clus-tered datasets. J. Clin. Epidemiol. 2021;137:83&#x2013;91. doi: 10.1016/j.jclinepi.2021.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2021.03.025</ArticleId><ArticleId IdType="pubmed">33836256</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; Vienna, Austria: 2022.</Citation></Reference><Reference><Citation>Robin X., Turck N., Hainard A., Tiberti N., Lisacek F., Sanchez J.C., M&#xfc;ller M. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77. doi: 10.1186/1471-2105-12-77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-12-77</ArticleId><ArticleId IdType="pmc">PMC3068975</ArticleId><ArticleId IdType="pubmed">21414208</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Yang S., Kong J., Dong A., Yu S. Obtaining information about protein secondary structures in aqueous solution using Fourier transform IR spectroscopy. Nat. Protoc. 2015;10:382&#x2013;396. doi: 10.1038/nprot.2015.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2015.024</ArticleId><ArticleId IdType="pubmed">25654756</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren S., Hinzman A.A., Kang E.L., Szczesniak R.D., Lu L.J. Computational and statistical analysis of metabo-lomics data. Metabolomics. 2015;11:1492&#x2013;1513. doi: 10.1007/s11306-015-0823-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-015-0823-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando T., Ishii M., Kamo M., Sato Y. H-D exchange reaction on diamond surfaces studied by diffuse reflec-tance Fourier transform IR spectroscopy. Diam. Relat. Mater. 1995;4:607&#x2013;611. doi: 10.1016/0925-9635(94)05242-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0925-9635(94)05242-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo D.W. Course Notes on the Interpretation of Infrared and Raman Spectra. John Wiley &amp; Sons; New Jersey, NJ, USA: 2004. Characteristic Frequencies of Alkanes; pp. 33&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471690082.CH2</ArticleId></ArticleIdList></Reference><Reference><Citation>West Virginia University . Infrared Spectroscopy. West Virginia University; Morgantown, WV, USA: 2016. Background; pp. 1&#x2013;7.</Citation></Reference><Reference><Citation>Roy S., Perez-Guaita D., Bowden S., Heraud P., Wood B.R. Spectroscopy goes viral: Diagnosis of hepatitis B and C virus infection from human sera using ATR-FTIR spectroscopy. Clin. Spectrosc. 2019;1:100001. doi: 10.1016/j.clispe.2020.100001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clispe.2020.100001</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K.Z., Shaw R.A., Man A., Dembinski T.C., Mantsh H.H. Reagent-free, simultaneous determination of serum cholesterol in HDL and LDL by infrared spectroscopy. Clin. Chem. 2002;48:499&#x2013;506. doi: 10.1093/clinchem/48.3.499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/48.3.499</ArticleId><ArticleId IdType="pubmed">11861440</ArticleId></ArticleIdList></Reference><Reference><Citation>California State University Stanislaus . Interpretation of Infrared Spectra. California State University Stanislaus; Turlock, CA, USA: 2023.</Citation></Reference><Reference><Citation>Amalanathan M., Joe I.H., Kostova I. Density functional theory calculation and vibrational spectral analysis of 4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one. J. Raman Spectrosc. 2010;41:1076&#x2013;1084. doi: 10.1002/jrs.2543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrs.2543</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayaraman V., Thiran S., Madden D.R. Fourier transform infrared spectroscopic characteriza-tion of a photolabile precursor of glutamate. FEBS Lett. 2000;475:278&#x2013;282. doi: 10.1016/S0014-5793(00)01690-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(00)01690-2</ArticleId><ArticleId IdType="pubmed">10869571</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenz-Fonfria V.A. Infrared Difference Spectroscopy of Proteins: From Bands to Bonds. Chem. Rev. 2020;120:3466&#x2013;3576. doi: 10.1021/acs.chemrev.9b00449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.9b00449</ArticleId><ArticleId IdType="pubmed">32202114</ArticleId></ArticleIdList></Reference><Reference><Citation>Pushie M.J., Messmer M., Sylvain N.J., Heppner J., Newton J.M., Hou H., Hackett M.J., Kelly M.E., Peeling L. Multimodal imaging of hemorrhagic transformation biomarkers in an ischemic stroke model. Metallomics. 2022;14:mfac007. doi: 10.1093/mtomcs/mfac007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/mtomcs/mfac007</ArticleId><ArticleId IdType="pmc">PMC9056027</ArticleId><ArticleId IdType="pubmed">35254441</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen I., Tokatli F. Differentiation of wines with the use of combined data of UV&#x2013;visible spectra and color characteristics. J. Food Compost. Anal. 2016;45:101&#x2013;107. doi: 10.1016/j.jfca.2015.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfca.2015.09.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrekar J.N. Receiver operating characteristic curve in diagnostic test assessment. J. Thorac. Oncol. 2010;5:1315&#x2013;1316. doi: 10.1097/JTO.0b013e3181ec173d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JTO.0b013e3181ec173d</ArticleId><ArticleId IdType="pubmed">20736804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira I.C.C., Aguiar E.M.G., Silva A.T.F., Santos L.L.D., Cardoso-Sousa L., Ara&#xfa;jo T.G., Santos D.W., Goulart L.R., Sabino-Silva R., Maia Y.C.P. Attenuated Total Reflection-Fourier Transform Infrared (ATR-FTIR) spectroscopy analysis of saliva for breast cancer diagnosis. J. Oncol. 2020;2020:1&#x2013;11. doi: 10.1155/2020/4343590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/4343590</ArticleId><ArticleId IdType="pmc">PMC7035572</ArticleId><ArticleId IdType="pubmed">32104176</ArticleId></ArticleIdList></Reference><Reference><Citation>Naseer K., Ali S., Qazi J. ATR-FTIR spectroscopy as the future of diagnostics: A systematic review of the approach using bio-fluids. Appl. Spectrosc. Rev. 2021;56:85&#x2013;97. doi: 10.1080/05704928.2020.1738453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/05704928.2020.1738453</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald C.T., Carter L.P. Possible role for glutamic acid decarboxylase in fibromyalgia symptoms: A conceptual model for chronic pain. Med. Hypotheses. 2011;77:409&#x2013;415. doi: 10.1016/j.mehy.2011.05.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2011.05.031</ArticleId><ArticleId IdType="pubmed">21684692</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyke T.L., Osmotherly P.G., Baines S. Measuring Glutamate Levels in the Brains of Fibromyalgia Patients and a Potential Role for Glutamate in the Pathophysiology of Fibromyalgia Symptoms: A Systematic Review. Clin. J. Pain. 2017;33:944&#x2013;954. doi: 10.1097/AJP.0000000000000474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AJP.0000000000000474</ArticleId><ArticleId IdType="pubmed">28033157</ArticleId></ArticleIdList></Reference><Reference><Citation>Holton K.F., Taren D.L., Thomson C.A., Bennett R.M., Jones K.D. The effect of dietary glutamate on fibromyalgia and irritable bowel symptoms. Clin. Exp. Rheumatol. 2012;30((Suppl. 74)):10&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">22766026</ArticleId></ArticleIdList></Reference><Reference><Citation>Radhakrishnan R., Sluka K.A. Increased glutamate and decreased glycine release in the rostral ventromedial medulla during induction of a pre-clinical model of chronic widespread muscle pain. Neurosci. Lett. 2009;457:141&#x2013;145. doi: 10.1016/j.neulet.2009.03.086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2009.03.086</ArticleId><ArticleId IdType="pmc">PMC2710144</ArticleId><ArticleId IdType="pubmed">19429181</ArticleId></ArticleIdList></Reference><Reference><Citation>Skyba D.A., Lisi T.L., Sluka K.A. Excitatory amino acid concentrations increase in the spinal cord dorsal horn after repeated intramuscular injection of acidic saline. Pain. 2005;119:142&#x2013;149. doi: 10.1016/j.pain.2005.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2005.09.025</ArticleId><ArticleId IdType="pubmed">16297556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggiero V., Mura M., Cacace E., Era B., Peri M., Sanna G., Fais A. Free amino acids in fibromyalgia syndrome: Relationship with clinical picture. Scand. J. Clin. Lab. Inv. 2017;77:93&#x2013;97. doi: 10.1080/00365513.2016.1269362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365513.2016.1269362</ArticleId><ArticleId IdType="pubmed">28079404</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>